Evaluation of the Role of IgE Responses to Der p 1 and Der p 2 in Chinese House Dust Mite-Allergic Patients
Study Details
Study Description
Brief Summary
One hundred patients were enrolled, based on sensitization and doctor-diagnosed allergy to HDM. Questionnaires were administered to document demographic and clinical characteristics. Serum IgE reactivity toDermatophagoides pteronyssinus (Dp) extract, Der p 1, Der p 2 and Der p 10 was measured by ImmunoCAP.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Detailed Description
Background: The role of specific IgE (sIgE) against Der p 1and Der p 2 in Chinese patients with house dust mite (HDM)allergy has not yet been well investigated.Methods: One hundred patients were enrolled, based on sensitization and doctor-diagnosed allergy to HDM. Questionnaires were administered to document demographic and clinical characteristics. Serum IgE reactivity toDermatophagoides pteronyssinus (Dp) extract, Der p 1, Der p 2 and Der p 10 was measured by ImmunoCAP.
Study Design
Outcome Measures
Primary Outcome Measures
- Demographic Characteristics [1 year]
Describe the patient's basic information in detail, including age, gender, family history, etc
- Der p 1 Serum IgE [1 year]
Prevalence of Der p 1 Serum IgE in HDM-Allergic Patients
- Der p 2 Serum IgE [1 year]
Prevalence of Der p 2 Serum IgE in HDM-Allergic Patients
- Dp, Der p 1 and Der p 2 [1 year]
Relationship between Serum IgE Levels of Dp, Der p 1 and Der p 2
- Factors associated with specific IgE against Der p 1 [1 year]
Study the patient's basic information and identify factors that are clearly associated with specific IgE against Der p 1
- Factors associated with specific IgE against Der p 2 [1 year]
Study the patient's basic information and identify factors that are clearly associated with specific IgE against Der p 2
- the Number of Affected Organs [1 year]
Association of Specific IgE Titers with the Number of Affected Organs
Eligibility Criteria
Criteria
Inclusion Criteria:
- HDM-allergic patients reporting allergic rhinitis, conjunctivitis, asthma and/or atopic dermatitis and who had never undergone immunotherapy, were enrolled if they were sensitized to Dp as judged by ImmunoCAP ( ≥ 1 kU/l) and/or skin reaction index (SRI)by skin-prick test (SPT, a wheal diameter ≥ 0.5 mm).
Exclusion Criteria:
- Patients who refused to participate in the study.
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Second Affiliated Hospital,School of Medicine,Zhejiang University | Hangzhou | Zhejiang | China |
Sponsors and Collaborators
- Second Affiliated Hospital, School of Medicine, Zhejiang University
Investigators
- Study Chair: Wang Huiying, 2nd affiliated Hospital,School of Medicine,Zhejiang University,China
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- 2012-047